COVID-19/Coronavirus Update

Learn how microLIQUID is responding to COVID-19

COVID-19 is at the top of the agenda for microLIQUID and as your trusted partner, we understand that the scientific community is impacted by the novel coronavirus outbreak. That is why we are committed to providing consistent support, so your work is not interrupted.

We are also aware that as a company developing Point of Care (POC) systems to test and detect for infectious diseases, our products are key in understanding the progression and nature of the disease.

Manufacturing Operations and Supply Chain

From microLIQUID we are confident that we will be able to maintain the supply of products and support in these challenging times.

We understand the potential disruption that the expanding COVID-19 pandemic will have on our customers. To that end, we have acted to secure our supply chain and maintain operations while protecting our employees. We have accelerated inventory buildup and have been working with our suppliers to ensure availability of raw materials.

Business Operations                                

microLIQUID is closely monitoring guidance from the WHO, and the government health departments regarding COVID-19 cases and responding quickly as the situation evolves.

microLIQUID will:

fast-forward (1) Continue offering, technical support through email and virtual methods

fast-forward (1) Set up virtual alternatives for sales meetings

 

We are here to help.

Please reach out to us if you require additional details or have questions: info@microLIQUID.com